10.54

1.93% 0.20

After Hours: 10.54

Avid Bioservices Inc (CDMO)

Overview News Price History Option Chain Financials Why CDMO Down? Discussions Forecast Stock Split

Avid Bioservices Inc stock is traded at $10.54, with a volume of 450.10K. It is up +1.93% in the last 24 hours and down -0.85% over the past month. Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Previous Close:

$10.34

Open:

$10.22

24h Volume:

450.10K

Relative Volume:

0.62

Market Cap:

$659.64M

Revenue:

$139.91M

Net Income/Loss:

$-140.75M

P/E Ratio:

-234.74

EPS:

-0.0449

Net Cash Flow:

$-20.85M

1W Performance:

+3.54%

1M Performance:

-0.85%

6M Performance:

+27.76%

1Y Performance:

+62.40%

1-Day Range:

$10.15

$10.54

1-Week Range:

$9.96

$10.56

52-Week Range:

$4.0705

$12.48

Avid Bioservices Inc Stock (CDMO) Company Profile

Name

Avid Bioservices Inc

Sector

Healthcare (1182)

Industry

Biotechnology (671)

Phone

714.508.6100

Address

14191 MYFORD ROAD, TUSTIN, CA

Employee

371

Twitter

Next Earnings Date

2024-09-09

Latest SEC Filings

CDMO's Discussions on Twitter

Avid Bioservices Inc Stock (CDMO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-28-23	Initiated	William Blair	Mkt Perform
Mar-14-23	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Dec-08-21	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-17-21	Initiated	RBC Capital Mkts	Outperform
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-10-19	Upgrade	First Analysis Sec	Outperform → Strong Buy
Oct-17-19	Initiated	Stephens	Overweight
Oct-16-19	Initiated	Craig Hallum	Buy
Jun-28-19	Upgrade	Janney	Neutral → Buy
May-09-19	Downgrade	Janney	Buy → Neutral

View All

Avid Bioservices Inc Stock (CDMO) Latest News

07:56 AM

Avid Closes Acquisition of Wolftech - Benzinga

07:56 AM

Nov 03, 2024

1,448,916 Shares in Avid Bioservices, Inc. (NASDAQ:CDMO) Bought by Emerald Advisers LLC - MarketBeat

Nov 03, 2024

Nov 02, 2024

Avid Bioservices, Inc. (NASDAQ:CDMO) Receives $13.50 Average Target Price from Analysts - Defense World

Nov 02, 2024

Oct 30, 2024

Brokerages Set Avid Bioservices, Inc. (NASDAQ:CDMO) Price Target at $13.50 - MarketBeat

Oct 30, 2024

Oct 29, 2024

Avid Bioservices (NASDAQ:CDMO) Shares Cross Above 200 Day Moving AverageHere's Why - MarketBeat

Oct 29, 2024

Oct 28, 2024

Avid Bioservices' Record-breaking Quarterly Revenue Ignites Hope For 2025 - RTTNews

Oct 28, 2024

Oct 26, 2024

Trend Tracker for (CDMO) - Stock Traders Daily

Oct 26, 2024

Oct 17, 2024

Avid Bioservices expands incentive plan and amends ESPP - Investing.com India

Oct 17, 2024

Avid Bioservices expands incentive plan and amends ESPP By Investing.com - Investing.com Australia

Oct 17, 2024

State Street Corp's Strategic Reduction in Avid Bioservices Inc Holdings - Yahoo Finance

Oct 17, 2024

Oct 15, 2024

Avid Bioservices' chief commercial officer sells shares worth $1,207 - Investing.com India

Oct 15, 2024

Avid Bioservices' chief commercial officer sells shares worth $1,207 By Investing.com - Investing.com Canada

Oct 15, 2024

How To Trade (CDMO) - Stock Traders Daily

Oct 15, 2024